MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The effectiveness and usability of online rehabilitation for Parkinson’s Disease patients

    S. Okusa, H. Saegusa, K. Miyakawa, Y. Tsutsumi, S. Ishida, K. Nishikata, T. Nukariya, T. Tezuka, Y. Nihei, Y. Kitagawa, S. Kubo, N. Suzuki, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The aim was to evaluate the effectiveness and utility of online rehabilitation program by conducting a survey using self-designed questionnaire, Parkinson’s Disease Questionnaire-39 (PDQ-39)…
  • 2023 International Congress

    SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication

    A. Patel, G. Forde, K. Martinez, A. Mayadev, B. Brucker, K. Becker Ifantides, R. Singh, M. Nelson, I. Yushmanova, S. Battucci, C. Rhyne (Overland Park, USA)

    Objective: Report real-world safety of onabotulinumtoxinA used concomitantly for multiple therapeutic indications. Background: Therapeutic onabotulinumtoxinA is approved in the US for 12 indications, some of…
  • 2023 International Congress

    Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort

    S. Weber, M. Dakna, A. Bednorz, M. Bartl, E. Lang, T. Wicke, M. Starke, J. Ebentheuer, F. Sixel-Döring, M. Muntean, S. Schade, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)

    Objective: To provide a reference of individual Parkinson’s disease (PD) progression by assessing multimodal milestones over 10 years (y) in patients of the DeNoPa cohort.…
  • 2023 International Congress

    Clinical severity in Parkinson’s disease is determined by decline in cortical compensation

    M. Johansson, I. Toni, R. Kessels, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: We tested whether inter- and intra-individual differences in clinical severity are determined by cortical compensation, and not just by basal ganglia dysfunction. Background: Motor…
  • 2023 International Congress

    Characterization of the pathogenic α-Synuclein variant p.V15A in Parkinson´s disease

    S H. Diaw, F. Buratti, L. Streubel-Gallasch, M. Borsche, M. Dulovic-Mahlow, C O. Fernández, J. Seeliger, I. Lenz, P. Seibler, C. Klein, N. Brüggemann, M. Zweckstetter, M. Vos, K. Lohmann (Lübeck, Germany)

    Objective: To investigate functional alterations of the p.V15A variant in alpha-Synuclein (α-Syn) in Parkinson's disease (PD). Background: PD is marked by the loss of dopaminergic…
  • 2023 International Congress

    Data-driven subtypes of multiple system atrophy and the implication on prognosis

    C-C. Fan, C. Han, X-M. Wang, W. Mao, E-H. Xu, P. Chan, S-Y. Liu (Beijing, China)

    Objective: To determine the clinical subtypes of MSA using data-driven approach and to compare the differences of the subtypes on survival and bed-ridden rates. Background:…
  • 2023 International Congress

    Experiences of People with Parkinson’s Disease use of a wearable technology for the management of drooling; qualitative insights from the Cue Band study

    L. Dismore, K. Montague, T. Guerreiro, L. Carvalho, D. Jackson, R. Walker (Newcastle upon Tyne, United Kingdom)

    Objective: In the Cue Band study, people with Parkinson’s Disease (PwP) are participating in a randomised controlled trial to compare a mobile Application (App) with…
  • 2023 International Congress

    Association of Early and late age of onset with Mitochondrial DNA haplogroup in Indian Spinocerebellar Ataxia type- 2 patients.

    A. Sonakar, M. Srivastava, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: To explore the role of mtHaplogroups in early and late onset SCA2 patients. Background: An unstable expansion of a CAG tract in the ATXN2…
  • 2023 International Congress

    Automated VMAT2 [18F]AV-133 PET analysis in Parkinson’s disease

    R. Manber, B. Brito Vega, C. Mcginnity (London, United Kingdom)

    Objective: To evaluate a fully automated image analysis pipeline to process vesicular monoamine transporters type 2 (VMAT2) [18F]AV-133 tracer positron emission tomography (PET) images, by…
  • 2023 International Congress

    MER length as a predictor of motor and non-motor outcomes of STN DBS in Parkinson’s disease

    K. Pillai, S. Joshua, A. Nair, D. Panikar, M. Chacko, A. Thalakkattu, A. Avarachan, H. Prakash, A. Kishore (Kochi, India)

    Objective: To test whether the length of the subthalamic nucleus (STN) in microelectrode recording (MER) can predict the 6-month motor and non-motor outcomes of DBS…
  • « Previous Page
  • 1
  • …
  • 223
  • 224
  • 225
  • 226
  • 227
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley